Report Detail

Request for Sample of this report

Other Global Pharmaceutical CDMO Solution Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4509849
    • |
  • 13 February, 2023
    • |
  • Global
    • |
  • 114 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Pharmaceutical CDMO Solution market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Pharmaceutical CDMO Solution market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharmaceutical CDMO Solution market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO Solution market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO Solution market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO Solution market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical CDMO Solution
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical CDMO Solution market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recipharm AB, Lonza Group, Catalent, Patheon (Thermo Fisher Scientific) and Siegfried AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Pharmaceutical CDMO Solution market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Development and Manufacturing
Secondary Packaging
Others
Market segment by Application
Innovative Medicine
Patented Drug
Patent Expired Drug
Others
Market segment by players, this report covers
Recipharm AB
Lonza Group
Catalent
Patheon (Thermo Fisher Scientific)
Siegfried AG
SGS Quay Pharmaceuticals
Curia
Societal CDMO
Aenova Group
Eurofins CDMO
Piramal Group
WuXi AppTec Group
Fareva
Strides Pharma Science
Famar Health Care Service
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical CDMO Solution product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical CDMO Solution, with revenue, gross margin and global market share of Pharmaceutical CDMO Solution from 2018 to 2023.
Chapter 3, the Pharmaceutical CDMO Solution competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmaceutical CDMO Solution market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical CDMO Solution.
Chapter 13, to describe Pharmaceutical CDMO Solution research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Pharmaceutical CDMO Solution
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Pharmaceutical CDMO Solution by Type
    • 1.3.1 Overview: Global Pharmaceutical CDMO Solution Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Pharmaceutical CDMO Solution Consumption Value Market Share by Type in 2022
    • 1.3.3 Active Pharmaceutical Ingredient (API) Manufacturing
    • 1.3.4 Finished Dosage Formulation (FDF) Development and Manufacturing
    • 1.3.5 Secondary Packaging
    • 1.3.6 Others
  • 1.4 Global Pharmaceutical CDMO Solution Market by Application
    • 1.4.1 Overview: Global Pharmaceutical CDMO Solution Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Innovative Medicine
    • 1.4.3 Patented Drug
    • 1.4.4 Patent Expired Drug
    • 1.4.5 Others
  • 1.5 Global Pharmaceutical CDMO Solution Market Size & Forecast
  • 1.6 Global Pharmaceutical CDMO Solution Market Size and Forecast by Region
    • 1.6.1 Global Pharmaceutical CDMO Solution Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Pharmaceutical CDMO Solution Market Size by Region, (2018-2029)
    • 1.6.3 North America Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)
    • 1.6.6 South America Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Recipharm AB
    • 2.1.1 Recipharm AB Details
    • 2.1.2 Recipharm AB Major Business
    • 2.1.3 Recipharm AB Pharmaceutical CDMO Solution Product and Solutions
    • 2.1.4 Recipharm AB Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Recipharm AB Recent Developments and Future Plans
  • 2.2 Lonza Group
    • 2.2.1 Lonza Group Details
    • 2.2.2 Lonza Group Major Business
    • 2.2.3 Lonza Group Pharmaceutical CDMO Solution Product and Solutions
    • 2.2.4 Lonza Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Lonza Group Recent Developments and Future Plans
  • 2.3 Catalent
    • 2.3.1 Catalent Details
    • 2.3.2 Catalent Major Business
    • 2.3.3 Catalent Pharmaceutical CDMO Solution Product and Solutions
    • 2.3.4 Catalent Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Catalent Recent Developments and Future Plans
  • 2.4 Patheon (Thermo Fisher Scientific)
    • 2.4.1 Patheon (Thermo Fisher Scientific) Details
    • 2.4.2 Patheon (Thermo Fisher Scientific) Major Business
    • 2.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product and Solutions
    • 2.4.4 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Patheon (Thermo Fisher Scientific) Recent Developments and Future Plans
  • 2.5 Siegfried AG
    • 2.5.1 Siegfried AG Details
    • 2.5.2 Siegfried AG Major Business
    • 2.5.3 Siegfried AG Pharmaceutical CDMO Solution Product and Solutions
    • 2.5.4 Siegfried AG Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Siegfried AG Recent Developments and Future Plans
  • 2.6 SGS Quay Pharmaceuticals
    • 2.6.1 SGS Quay Pharmaceuticals Details
    • 2.6.2 SGS Quay Pharmaceuticals Major Business
    • 2.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product and Solutions
    • 2.6.4 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 SGS Quay Pharmaceuticals Recent Developments and Future Plans
  • 2.7 Curia
    • 2.7.1 Curia Details
    • 2.7.2 Curia Major Business
    • 2.7.3 Curia Pharmaceutical CDMO Solution Product and Solutions
    • 2.7.4 Curia Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Curia Recent Developments and Future Plans
  • 2.8 Societal CDMO
    • 2.8.1 Societal CDMO Details
    • 2.8.2 Societal CDMO Major Business
    • 2.8.3 Societal CDMO Pharmaceutical CDMO Solution Product and Solutions
    • 2.8.4 Societal CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Societal CDMO Recent Developments and Future Plans
  • 2.9 Aenova Group
    • 2.9.1 Aenova Group Details
    • 2.9.2 Aenova Group Major Business
    • 2.9.3 Aenova Group Pharmaceutical CDMO Solution Product and Solutions
    • 2.9.4 Aenova Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Aenova Group Recent Developments and Future Plans
  • 2.10 Eurofins CDMO
    • 2.10.1 Eurofins CDMO Details
    • 2.10.2 Eurofins CDMO Major Business
    • 2.10.3 Eurofins CDMO Pharmaceutical CDMO Solution Product and Solutions
    • 2.10.4 Eurofins CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Eurofins CDMO Recent Developments and Future Plans
  • 2.11 Piramal Group
    • 2.11.1 Piramal Group Details
    • 2.11.2 Piramal Group Major Business
    • 2.11.3 Piramal Group Pharmaceutical CDMO Solution Product and Solutions
    • 2.11.4 Piramal Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Piramal Group Recent Developments and Future Plans
  • 2.12 WuXi AppTec Group
    • 2.12.1 WuXi AppTec Group Details
    • 2.12.2 WuXi AppTec Group Major Business
    • 2.12.3 WuXi AppTec Group Pharmaceutical CDMO Solution Product and Solutions
    • 2.12.4 WuXi AppTec Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 WuXi AppTec Group Recent Developments and Future Plans
  • 2.13 Fareva
    • 2.13.1 Fareva Details
    • 2.13.2 Fareva Major Business
    • 2.13.3 Fareva Pharmaceutical CDMO Solution Product and Solutions
    • 2.13.4 Fareva Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Fareva Recent Developments and Future Plans
  • 2.14 Strides Pharma Science
    • 2.14.1 Strides Pharma Science Details
    • 2.14.2 Strides Pharma Science Major Business
    • 2.14.3 Strides Pharma Science Pharmaceutical CDMO Solution Product and Solutions
    • 2.14.4 Strides Pharma Science Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Strides Pharma Science Recent Developments and Future Plans
  • 2.15 Famar Health Care Service
    • 2.15.1 Famar Health Care Service Details
    • 2.15.2 Famar Health Care Service Major Business
    • 2.15.3 Famar Health Care Service Pharmaceutical CDMO Solution Product and Solutions
    • 2.15.4 Famar Health Care Service Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Famar Health Care Service Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Pharmaceutical CDMO Solution Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Pharmaceutical CDMO Solution by Company Revenue
    • 3.2.2 Top 3 Pharmaceutical CDMO Solution Players Market Share in 2022
    • 3.2.3 Top 6 Pharmaceutical CDMO Solution Players Market Share in 2022
  • 3.3 Pharmaceutical CDMO Solution Market: Overall Company Footprint Analysis
    • 3.3.1 Pharmaceutical CDMO Solution Market: Region Footprint
    • 3.3.2 Pharmaceutical CDMO Solution Market: Company Product Type Footprint
    • 3.3.3 Pharmaceutical CDMO Solution Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Pharmaceutical CDMO Solution Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Pharmaceutical CDMO Solution Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Pharmaceutical CDMO Solution Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Pharmaceutical CDMO Solution Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
  • 6.2 North America Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
  • 6.3 North America Pharmaceutical CDMO Solution Market Size by Country
    • 6.3.1 North America Pharmaceutical CDMO Solution Consumption Value by Country (2018-2029)
    • 6.3.2 United States Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
  • 7.2 Europe Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
  • 7.3 Europe Pharmaceutical CDMO Solution Market Size by Country
    • 7.3.1 Europe Pharmaceutical CDMO Solution Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
    • 7.3.3 France Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region
    • 8.3.1 Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Region (2018-2029)
    • 8.3.2 China Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
    • 8.3.5 India Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
  • 9.2 South America Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
  • 9.3 South America Pharmaceutical CDMO Solution Market Size by Country
    • 9.3.1 South America Pharmaceutical CDMO Solution Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country
    • 10.3.1 Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Pharmaceutical CDMO Solution Market Drivers
  • 11.2 Pharmaceutical CDMO Solution Market Restraints
  • 11.3 Pharmaceutical CDMO Solution Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Pharmaceutical CDMO Solution Industry Chain
  • 12.2 Pharmaceutical CDMO Solution Upstream Analysis
  • 12.3 Pharmaceutical CDMO Solution Midstream Analysis
  • 12.4 Pharmaceutical CDMO Solution Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pharmaceutical CDMO Solution. Industry analysis & Market Report on Pharmaceutical CDMO Solution is a syndicated market report, published as Global Pharmaceutical CDMO Solution Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Pharmaceutical CDMO Solution market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,742.24
    		4,113.36
    		5,484.48
    		3,201.60
    		4,802.40
    		6,403.20
    		542,149.20
    		813,223.80
    		1,084,298.40
    		290,092.80
    		435,139.20
    		580,185.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo